Trial Details

Not Recruiting
Basic Information
Clinical ID c3016
Identifier DRKS00008174
Trial Title Vedolizumab register in patients with inflammatory bowel disease in Germany - VEDOibd
Trial URL Visit Original Page
Study Information
Study Results

Yes

Conditions K50;Crohn disease [regional enteritis]
Interventions Group 1: Effectiveness of therapy and serious adverse events with a Vedolizumab therapy in patients with inflammatory bowel disease. Data on drug history , disease history and the well-being of the patient are recorded.
Participant Information
Sponsor CED Service GmbH
City -
Country/Region Germany
Enrollment Criteria
Sex Requirement ALL
Age Requirement -
Study Design
Study Type observational
Phase Not Available
Time Information
Start Date 2025-04-24
Primary Completion Date 2016-10-11
Completion Date 2017-04-10